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Trace conditioning procedures test the cognitive capacity to associ‐
ate events separated by an intervening time or “trace” interval. This 
requires working memory for the moment‐to‐moment processing 
necessary to bridge the temporal discontiguity (Levy & Goldman‐
Rakic, 2000; Sweatt, 2004). Trace conditioning has been shown to be 
impaired by the use of the muscarinic acetylcholine (ACh) antagonist 
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Abstract
Introduction: Trace conditioning is impaired by lesions to dorsal hippocampus, as 
well as by treatment with the muscarinic acetylcholine antagonist scopolamine. 
However, the role of muscarinic receptors within hippocampus has received little 
attention.
Methods: The present study examined the effects of intra‐hippocampal infusion of 
scopolamine (30 µg/side) in an appetitive (2 vs. 10 s) trace conditioning procedure 
using sucrose pellets as the unconditioned stimulus (US). Locomotor activity (LMA) 
was examined in a different apparatus.
Results: Intra‐hippocampal scopolamine reduced responding to the 2 s trace condi‐
tioned stimulus (CS). Intra‐hippocampal scopolamine similarly depressed responding 
within the inter‐stimulus interval (ISI) at both 2 and 10 s trace intervals, but there was 
no such effect in the inter‐trial interval. There was also some overall reduction in re‐
sponding when the US was delivered; significant at the 10 s but not at the 2 s trace 
interval. A similar pattern of results to that seen in response to the CS during acquisi‐
tion was shown drug‐free (in the 5 s post‐CS) in the extinction tests of conditioned 
responding. LMA was increased under scopolamine.
Conclusions: The results suggest that nonspecific changes in activity or motivation 
to respond for the US cannot explain the reduction in trace conditioning as measured 
by reduced CS responding and in the ISI. Rather, the findings of the present study 
point to the importance of associative aspects of the task in determining its sensitiv‐
ity to the effects of scopolamine, suggesting that muscarinic receptors in the hip‐
pocampus are important modulators of short‐term working memory.
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scopolamine in eyeblink (Kaneko & Thompson, 1997), fear condi‐
tioning (Hunt & Richardson, 2007), and appetitive conditioning pro‐
cedures (Seager, Asaka, & Berry, 1999). The hippocampus has been 
identified as a key neural substrate of the ability to bridge temporal 
discontiguity, which is essential to the acquisition of trace condition‐
ing (Bangasser, Waxler, Santollo, & Shors, 2006; Weible, O’Reilly, 
Weiss, & Disterhoft, 2006). The consolidation or expression of trace 
fear conditioning (measured after post‐training lesions) has also 
been found to depend on (dorsal) hippocampus (Quinn, Oommen, 
Morrison, & Fanselow, 2002). There is moreover some evidence to 
suggest that muscarinic ACh receptors modulate both the acquisi‐
tion and expression of trace fear conditioning (Pang et al., 2010). 
Specifically, injection of the muscarinic antagonist scopolamine in 
dorsal hippocampus (before the conditioning or the test stages of 
the procedure) impaired trace fear conditioning (Pang et al., 2010).
The majority of studies conducted to examine the neural sub‐
strates of trace conditioning have used aversive eyeblink (Chen et al., 
2014; Thomas & Tran, 2012; Weible et al., 2006; Weible, McEchron, 
& Disterhoft, 2000; Weible, Weiss, & Disterhoft, 2003) or fear con‐
ditioning (Bang & Brown, 2009; Bangasser et al., 2006; Baysinger, 
Kent, & Brown, 2012; Pang et al., 2010; Quinn et al., 2002) proce‐
dures. These studies have included examination of the effects of 
scopolamine administered directly by microinfusion, for example, in 
perirhinal cortex (Bang & Brown, 2009) and amygdala (Baysinger et 
al., 2012), in both cases using rats tested with a 16 s trace interval 
in a conditioned freezing procedure. Similarly, trace fear condition‐
ing was impaired after scopolamine infusion in dorsal hippocampus 
(Pang et al., 2010), but—to our knowledge—there has been no further 
examination of the role of scopolamine administered directly into 
the hippocampus.
Fear conditioning procedures necessarily involve the use of 
foot shocks. These need not be very aversive in order to motivate 
learning, but the adoption of appetitive task variants offers the 
opportunity to further refine procedures. Notably, however, the 
demonstration of hippocampal lesion effects in appetitive trace 
conditioning procedures has been challenging (Thibaudeau, Doré, & 
Goulet, 2009; Thibaudeau, Potvin, Allen, Doré, & Goulet, 2007) and 
it is important to consider temporal factors such as the timing of 
conditioned responses (Tam & Bonardi, 2012) as well as the length 
of the trace interval in relation to the inter‐trial interval (ITI; Chan, 
Shipman, & Kister, 2014).
Seager et al. (1999) reported that a disruption of appetitive trace 
conditioning was produced by central cholinergic blockade (fol‐
lowing subcutaneous administration of scopolamine hydrobromide 
but not scopolamine methyl bromide) and electrophysiological re‐
sponses provided evidence that this effect was mediated in hippo‐
campus. However, these findings have yet to be confirmed by direct 
infusion of scopolamine into hippocampus. To address these gaps in 
the evidence base, the present study therefore set out to test the im‐
portance of cholinergic signaling in hippocampus using an appetitive 
trace conditioning procedure.
Specifically, we examined the effects of scopolamine infused into 
dorsal hippocampus (30 µg/side; Pang et al., 2010) in an appetitive 
procedure identical to that which we have used previously to com‐
pare conditioning at 2 s and 10 s trace intervals following microin‐
fusions in prefrontal cortex (mPFC) sub‐regions (Pezze, Marshall, & 
Cassaday, 2015, 2017). We also tested the effects of the same sco‐
polamine treatment on locomotor activity (LMA).
As noted above, the replication of the effects of hippocampal 
lesions, reliably shown in aversive trace conditioning, has been chal‐
lenging when appetitive procedures are used (Chan et al., 2014; 
Tam & Bonardi, 2012; Thibaudeau et al., 2007, 2009). We therefore 
sought to test the generality of the finding that intra‐hippocampal 
scopolamine impairs trace conditioning (Pang et al., 2010), using the 
same appetitive procedure which previously showed sensitivity to 
scopolamine administered systemically (as well as in mPFC; Pezze, 
et al., 2017).
Based on these previous findings from our laboratory, it was an‐
ticipated that scopolamine would impair trace conditioning at the 
2 s trace interval. Previous findings suggest that floor effects can 
preclude the demonstration of any further impairment in trace con‐
ditioning at the 10 s trace interval. The use of the 10 s trace was nev‐
ertheless retained in the present study because conditioning at the 
higher level of temporal discontiguity would be expected to be more 
dependent on hippocampal function. Other appetitive trace stud‐
ies (e.g., Chan et al., 2014; Thibaudeau et al., 2007) have compared 
short and long trace intervals similar to those used in the present 
experiment. Moreover, we also routinely examine the distribution of 
responding within the longer 10 s trace interval (Pezze et al., 2015, 
2017; Tam & Bonardi, 2012). Extinction tests were conducted drug‐
free as a further control measure, for scopolamine effects on motor 
responding. Delay conditioning groups were not included because 
appetitive delay conditioning is not impaired by hippocampal lesions 
(Thibaudeau et al., 2007, 2009), and the available evidence shows no 
effect of scopolamine on (in this case, aversive) delay conditioning 
(Pang et al., 2010; Pezze et al., 2017).
2  | MATERIAL S AND METHODS
2.1 | Subjects
Forty experimentally naïve male Wistar rats were used (Charles 
Rivers, UK; 170–213 g; mean 191 g). Two of the subjects died under 
anesthetic due to surgical complications, and a third was humanely 
euthanized after the third day of conditioning because of nonspe‐
cific symptoms that might have developed in severity. Rats were 
weighed daily following surgery, and all the other animals used in the 
present study recovered well.
Throughout the study, rats were housed in groups of 3–4 per 
cage, on a 12:12‐hr dark/light cycle and on ad libitum water. Food was 
freely available up until 24 hr before shaping. Rats were handled for 
approximately 10 min/day over the course of one week, during which 
time they reached full adult weight (261–299 g; mean 280 g) prior 
to surgery, which was also conducted over 1 week. Shaping com‐
menced after at least 1 week of post‐operative recovery, throughout 
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which rats were monitored daily and habituated to the manual han‐
dling techniques that would be used to restrain them during the 
microinfusion procedure (weights at the start of food deprivation 
297–376 g; mean 335 g). Weight gain was variable post‐operatively, 
but because we used vehicle‐injected controls, all the rats had the 
same experience aside from the infusion of scopolamine over the 
4 days of conditioning. Allocations to experimental (drug and trace) 
groups were weight‐matched as far as possible.
In total, 37 rats completed the trace conditioning procedures and 
24 of the same rats were subsequently tested in the LMA chambers 
during the week following the appetitive conditioning (i.e., 4 days 
after the completion of the extinction tests). Animals were selected 
to be (as far as possible) weight‐matched in the vehicle‐ and scopol‐
amine‐infused groups as well as counterbalanced for their previous 
infusion condition.
All procedures were carried out in accordance with the princi‐
ples of laboratory animal care, specifically the United Kingdom (UK) 
Animals Scientific Procedures Act 1986, Project Licence Number: 
PPL 40/3716. Under this licence, we are required to maintain adult 
rats in the range 200–300 g, this range increasing to 300–400 g for 
older cohorts, and any drop below 80% initial free‐feeding weight 
requires compensatory feeding with wet mash. Our criteria for re‐
covery from the surgery before any food restriction is introduced in‐
clude a 10% increase in body weight; the weight gain was a minimum 
of 13% for this particular batch of animals.
2.2 | Apparatus
Four fully automated conditioning boxes housed within sound‐at‐
tenuating cases containing ventilation fans (Cambridge Cognition, 
Cambridge, UK) were used. The conditioning boxes were steel 
(25 cm × 25 cm × 22 cm high) with a Plexiglas door (27 cm × 21 cm 
high), inset at the front. The food magazine (recessed in a side wall 
of each of the chambers) was constantly illuminated whenever food 
was available and accessed via a flap. Nose‐pokes were recorded by 
the breaking of the photobeam within the food magazine. The uncon‐
ditioned stimulus (US) was two 45 mg sucrose pellets dispensed into 
the magazine (Formula F, Noyes Precision Food, New Hampshire, 
UK). The conditioned stimulus (CS) was a mixed frequency noise, 
presented via a loudspeaker in the roof of the chamber, set at 72 dB 
including background and of 5 s duration.
Additionally, an experimental background stimulus was provided 
by three wall‐mounted stimulus lights and the house light flashing on 
(0.5 s) and off (0.5 s), continuously for the duration of the condition‐
ing session. Stimulus control and data collection were by an Acorn 
Archimedes RISC computer programmed in Basic with additional in‐
terfacing using an Arachnid extension (Cambridge Cognition).
Locomotor activity was measured in a dimly lit (50–70 Lux) room 
in 12 clear Perspex chambers (39.5 cm long × 23.5 cm wide × 24.5 cm 
deep) with metal grid lids. The chambers were surrounded by frames 
containing two levels of photobeams (Photobeam Activity System, 
San Diego Instruments, USA) as described previously (Jones, Brown, 
Auer, & Fone, 2011; Pezze, Marshall, Fone, & Cassaday, 2015; Pezze 
et al., 2017).
2.3 | Implantation of guide cannulae into the dorsal 
hippocampus
Rats were anesthetized using isoflurane delivered in oxygen (induc‐
tion: 4%–5%; maintenance: 1%–3%) and secured in a stereotaxic 
frame. All surgical procedures were carried out under aseptic condi‐
tions: A sterilized scalpel blade was used to expose the skull, and 
burr holes were drilled to allow the implantation of bilateral infusion 
guide cannulae (3.0 mm apart).
To reduce the risk of animals experiencing pain upon recovery 
from the general anesthetic, the incision was treated with the local 
anesthetic lidocaine and all rats were injected with the nonsteroi‐
dal anti‐inflammatory Rimadyl (1:9; 0.8 ml/kg, s.c.). The tips of the 
guide cannulae were aimed 0.5 mm above the injection sites in dor‐
sal hippocampus. The specific coordinates were ±1.5 mm lateral, 
−3	mm	posterior	from	bregma,	and	−3.5	mm	ventral	from	the	skull	
surface. The cannulae were secured using four stainless steel screws 
and dental acrylic. To reduce the risk of infection, plastic stylets 
were inserted into the tubes and closed with a plastic dust cap. Rats 
were placed in a recovery incubator before being reintroduced to 
their cages. Because of the previous incidence of meningitis (Pezze 
et al., 2015, 2017), the antibiotic Synulox (Ready‐To‐Use, Pfizer Ltd; 
0.05 ml kg‐1 day‐1, s.c.) was administered as a prophylactic measure.
2.4 | Microinfusion procedure
Scopolamine was prepared in a concentration of 60 µg/µl saline 
for injection in 0.5 μl volumes to deliver a dose of 30 µg/side. Rats 
were carefully restrained whilst the injectors were inserted into the 
cannulae guides into the dorsal hippocampus for direct infusion. 
Two lengths of polythene tubing were used to connect the injec‐
tion syringes to the injectors. The two syringes were mounted on a 
motorized microinfusion pump, programmed to deliver 0.5 μl of sco‐
polamine or saline vehicle, bilaterally over 2 min, plus an additional 
1 min after infusion for further diffusion. The four conditioning ses‐
sions started 10 min after the infusions during which time the rats 
were monitored for adverse effects following the infusion (none was 
detected). LMA tests followed immediately on completion of the in‐
fusion, to document the onset and course of scopolamine effects.
2.5 | Trace procedure
One day prior to shaping, food was removed in the morning and 
the rats were introduced to sucrose pellets in the home cage later 
the same day before being fed standard laboratory chow rationed 
at 5 g/100 g body weight. Behavioral procedures were identical 
to those used to examine the effects of scopolamine microinfused 
in mPFC (Pezze et al., 2017). Each rat was repeatedly infused with 
either saline or scopolamine prior to each of the four conditioning 
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sessions; the rats were not infused prior to the two extinctions ses‐
sion. The trace procedure is summarized in Table 1.
2.6 | Preconditioning
There were two days of shaping to accustom rats to eating from the 
magazine (starting with the tray flaps propped open by a teaspoon‐
ful of sucrose pellets; and conducted in pairs of cage mates and with 
the outer case door open until each rat was noted to take food). 
There then followed two days of baseline sessions, during which 
there were 30 unsignaled rewards (each of two sucrose pellets) over 
60 min, delivered on a variable interval around 120 s, to habituate 
rats to the sounds produced by food delivery.
2.7 | Conditioning
There were 4 days of conditioning at 30 trials per day. Depending 
on the experimental group, the sucrose pellet reward (US) was de‐
livered at a 2 s or 10 s inter‐stimulus interval (ISI), measured from 
CS offset to US delivery (in the two different trace groups). On each 
conditioning day, 30 signaled rewards were presented on a variable 
interval around 120 s, with the constraint that the ITI was always at 
least 1.5 times longer than the ISI length, that is, minimum 3 s for 
the 2 s and 15 s for the 10 s trace conditioned groups. Although the 
minimum ITI depended on trace condition in use, the average ITI was 
the same for the 2 s and 10 s trace groups because in each case the 
trace interval in use added to the overall duration of a 60‐min ses‐
sion (taking this to 61 or 65 min in total, respectively). Throughout 
acquisition, the background stimulus (flashing lights) was presented 
continuously. As per previous studies, this continuous presentation 
also encompassed the 2 s or 10 s ISI, as applicable (Pezze et al., 2015, 
2017).
Extinction tests of conditioning to the CS (noise) and experimen‐
tal background (flashing lights) stimuli were conducted in a coun‐
terbalanced order, 24 and 48 hr after conditioning procedures had 
been completed. In each case, there were thirty 5 s presentations of 
the stimulus under test, over the course of a 60‐min session. Stimuli 
were presented at a 120 s variable interval (the same for all groups, 
without the minimum related to the trace interval in use as per the 
conditioning stage).
2.8 | Locomotor activity
Two consecutive breaks of adjacent beams within the lower level of 
photobeams generated a locomotor count. To start a session, rats 
were placed into the center of the chamber. On the day before the 
LMA tests, each rat was habituated to its allocated activity cham‐
ber for 30 min (drug free). Then, on the test day there was a further 
30‐min habituation. Each rat was then removed for drug treatment 
and then immediately replaced in its allocated LMA chamber. Total 
locomotor counts were recorded for each consecutive 10‐min epoch 
for a further 60 min.
2.9 | Design and analysis
Four between‐subjects experimental groups were specified by the 
trace condition (2 or 10 s) and drug (saline or scopolamine microinfu‐
sion). The analyses of variance (ANOVAs) were run as mixed facto‐
rial designs using SPSS, with within‐subjects factors related to the 
passage of time (days, blocks of trials within day 1, bins within the 
trace). Specifically, there was a repeated‐measures factor of days (at 
four levels) for acquisition, which was examined in 2 × 2 × 4 designs. 
Effects on the initial acquisition of responding to the CS were fur‐
ther examined on day 1, in relation to blocks of five trials (at six lev‐
els) in a 2 × 2 × 6 design.
The dependent variable was the number of nose‐pokes into the 
food magazine (recorded as totals) in different periods of the con‐
ditioning sessions. Thus, the same dependent variable was used to 
index anticipatory responding during the 5 s presentations of the CS 
and in the ISI trace interval. To try to distinguish effects on moti‐
vation for food reward or motor responding, similar analyses were 
conducted on consummatory responding during the 5 s following US 
delivery as well as on ITI responding in the remainder of the session 
(excluding the trace ISI). Responding in the variable ITIs was summed 
over the session and captured as total “residual” responding. We also 
looked at ITI responding in the 5 s immediately pre‐CS, for a com‐
parison measure of responding just before each trial. However, the 
response rates in the 5 s ITI immediately pre‐CS were very low and 
unsuitable for ANOVA.
TA B L E  1   The trace conditioning schedule by experimental day, 
drug treatment, and stimuli presented within the conditioning 
boxes. Following two days shaping to accustom rats to eating from 
the magazine, pre‐1 and pre‐2 refer to the baseline sessions 
conducted with automated unsignaled food deliveries. D1 to D4 
refer to the 4 days of trace conditioning, on each of which tone was 
followed by food at the 2 s or 10 s trace interval, for a 30 trials per 
day and in the presence of the experimental background (flashing 
lights) stimulus. Tests 1 and 2 refer to the presentation of the noise 
and flashing lights (in counterbalanced order) to provide extinction 
measures of the strength of the associations
Conditioning day Drug treatment Stimuli
Shaping Drug‐free Food
Shaping Drug‐free Food
Pre‐1 baseline Drug‐free Food
Pre‐2 baseline Drug‐free Food
Trace—D1 Scopolamine 30 × tone‐food (within 
flashing light)
Trace—D2 Scopolamine 30 × tone‐food (within 
flashing light)
Trace—D3 Scopolamine 30 × tone‐food (within 
flashing light)
Trace—D4 Scopolamine 30 × tone‐food (within 
flashing light)
Test 1 Drug‐free Tone or flashing light
Test 2 Drug‐free Flashing light or tone
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Additionally, the responding of the animals during the trace in‐
terval between CS offset and US delivery was also examined, sep‐
arately for the 2 s and 10 s conditioned groups as the intervals in 
use were not directly comparable. Moreover, the 10 s ISI was broken 
down into five 2 s bins of time and analyzed using repeated‐mea‐
sures ANOVAs by bins as well as days, with the between‐subjects 
factor of drug. These analyses were 2 × 5 × 4 because trace was no 
longer a factor.
Extinction day test results were examined using 2 × 2 multivari‐
ate ANOVAs, to examine the effects of prior infusion of scopolamine 
by trace condition on total responding, during the CS, 5 s post‐CS, 
and in the remainder of the ITI. The equivalent analyses were also 
run for the extinction session testing responding to the background 
light stimulus. As per the early acquisition data, the course of extinc‐
tion was similarly examined over six blocks of 5 s presentations, for 
both the previously trained CS and the background light stimulus, in 
2 × 2 × 6 ANOVAs.
For interactions between scopolamine infusion (drug) and the 
repeated‐measures factors, we report the results of the within‐sub‐
jects contrasts (trend analyses). Differences relating to drug group 
were also followed up by post hoc tests using Fisher’s LSD test.
The LMA data were analyzed by mixed ANOVAs with the be‐
tween‐subjects factor of drug (saline or scopolamine microinfusion) 
by blocks of 10 min, at three levels for the 30‐min test day habit‐
uation, and six levels for the 60‐min testing under drug, in 2 × 3 
and 2 × 6 designs, respectively. The dependent variable was beam 
breaks.
3  | RESULTS
No rats needed to be excluded on histological grounds, leaving a 
final sample size of 37 (n = 9–10/group). The number of infusions 
was 4–5, because 24 of the same rats (which had been infused 
for the 4 days of conditioning) were subsequently tested in LMA, 
requiring an additional infusion. Figure 1a shows a representa‐
tive histological section; there was little evidence of damage at 
the cannula tip. Figure 1b illustrates the full range of cannula 
placements.
There was some missing data capture (four rats’ data from the 
second preconditioning day; and the breakdown by trial blocks was 
lost for three rats’ CS extinction tests).
3.1 | Effects of scopolamine in dorsal hippocampus 
on appetitive trace conditioning
3.1.1 | Preconditioning (drug free)
All the reward pellets were consumed, and the rats were confirmed 
to be nose‐poking freely following the shaping procedure. There 
were no effects involving drug condition‐to‐be on responding in the 
individual baseline sessions, maximum F(1,30) = 2.785, p = 0.106.
F I G U R E  1   (a) Photograph of a representative placement which 
illustrates the area around the injection which is also representative 
of the degree of gliosis seen as a result of the microinfusions. 
(b) Approximate locations of infusion cannula tips, in the dorsal 
hippocampus. Placements are shown on coronal plates adapted 
from Paxinos and Watson (1998), with numbers indicating distance 
from bregma in millimeters
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3.1.2 | ITI responding (following infusions)
There were no effects involving drug, and so no evidence for any 
reduction of responding after microinfusion of scopolamine, in the 
ITI, maximum F(3,99) = 2.020, p = 0.116. In the ITI, there was just 
a main effect of days, F(3,99) = 5.791, p = 0.001, because of an 
overall reduction in responding over the 4 days of testing (day 1 
M = 177.258 ± 16.725; day 4 M = 135.497 ± 13.953). Figure 2 (panel 
a) shows the 5 s ITI just preceding the 5 s CS presentations, for direct 
comparison with subsequent CS and US responding. As can be seen 
in the figure, the response rates in the 5 s ITI immediately pre‐CS 
were very low and unsuitable for ANOVA.
3.1.3 | CS responding (following infusions)
Rats conditioned at the 2 s trace responded progressively more 
to the CS over the 4 days of testing (day 1 M = 27.033 ± 3.930; 
day 4 M = 49.800 ± 4.271) whilst rats conditioned at the 10 s trace 
responded progressively less (day 1 M = 20.944 ± 4.032; day 4 
M = 12.167 ± 4.382). There was a significant trace × days interac‐
tion, F(3,99) = 11.194, p < 0.001, as well as a main effect of trace 
F(1,33) = 27.792, p < 0.001. There were no drug effects involving 
days, but there was both a main effect of drug, F(1,33) = 14.562, 
p = 0.001, and a drug × trace interaction, F(1,33) = 5.684, 
p = 0.023. As shown in Figure 2 (panel b), responding to the CS 
was overall reduced under scopolamine and this effect was sig‐
nificant for the 2 s, p < 0.001, but not the 10 s trace conditioned 
groups, p = 0.325. Within day 1, the analysis by trial blocks 
showed an interaction between blocks and drug, F(5,170)=4.408, 
p = 0.001, consistent with the possibility that scopolamine mi‐
croinfusions depressed the course of early acquisition, and this 
effect was also significant in the linear trend, F(1,43) = 11.435, 
p = 0.002. However, there was no effect of drug × trace × blocks, 
F(5,170) = 1.139, p = 0.342, so the daily averages are shown in 
Figure 2b.
3.1.4 | US responding (following infusions)
Responding overall dropped from day 1 (M = 47.700 ± 4.022) 
to day 4 (M = 42.706 ± 3.485) except in the scopolamine 2 s 
group, which showed some increase from a lower baseline (day 1 
M = 37.333 ± 8.147; day 4 M = 44.333 ± 7.059). Statistically, there 
was a trace × drug × days interaction, F(3,99) = 3.084, p = 0.031, sig‐
nificant also in the linear trend, F(1,33) = 6.664, p = 0.014. As shown 
in Figure 2 (panel c), responding following US deliveries was over‐
all reduced under scopolamine. Statistically, this was reflected in a 
main effect of drug, F(1,33) = 5.613, p = 0.024. However, in contrast 
to the effect on CS responding, this effect was significant for the 
10 s, p = 0.023, but not the 2 s trace conditioned groups, p = 0.354. 
Importantly, and irrespective of trace condition, pellets were none‐
theless found to be eaten at the end of each conditioning session.
3.1.5 | ISI responding (following infusions)
2 s trace group
There was a main effect of days, F(3,51) = 28.407, p < 0.001, and a 
drug x days interaction, F(3,51) = 6.875, p = 0.001, which was also sig‐
nificant in the linear trend, F(1,17) = 7.637, p = 0.013. There was also a 
main effect of drug, F(1,17) = 22.375, p < 0.001. Responding in the 2 s 
ISI progressively increased over the 4 days of conditioning, but this 
effect was less marked in rats treated with scopolamine (Figure 3a).
10 s trace group
There was an effect of bins because responding was not uniformly 
distributed within the 10 s trace, F(4,192) = 2.779, p = 0.034, with 
some relatively increased responding toward the middle to later 
portion of the trace interval but not the final bin, suggesting that 
timing was not fully developed (bin 1 M = 1.956 ± 0.422; bin 2 
M = 2.333 ± 0.261; bin 3 M = 2.113 ± 0.385; bin 4 M = 2.791 ± 0.450; 
bin 5 M = 1.833 ± 0.362). However, (the acquisition of) this dis‐
tribution was unaffected by drug, which was significant only as a 
F I G U R E  2   Mean nose‐pokes are shown as a function of the 4 days of conditioning (D1 to D4) for (a) the 5 s of the inter‐trial interval (ITI) 
just prior to conditioned stimulus (CS) presentation (pre‐CS) as compared to those (b) during the 5 s CS presentation or (c) in the 5 s when 
food was delivered (US). Diamonds denote rats conditioned at the 10 s trace interval, and circles denote rats conditioned at the 2 s trace 
interval after bilateral scopolamine infusion (30 µg in 0.5 µl/side) in dorsal hippocampus (black fill). White fill denotes control groups of rats 
conditioned after microinfusion of saline vehicle. N = 9–10 rats per group. Error bars represent the standard error of the mean
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main effect, F(1,16) = 5.467, p = 0.033. Scopolamine‐treated rats 
responded overall less in the 10 s ISI (Figure 3b). In contrast to 
what was seen in the 2 s trace group, the drug x days interaction 
was not significant, F(3,48) = 2.019, p = 0.124, in the linear trend, 
F(1,16) = 4.344, p = 0.054. There was no interaction between drug 
and bin, F(4,64) = 1.158, p = 0.338.
3.1.6 | Extinction tests (drug free)
Noise CS
There was no overall effect of prior trace or drug group on over‐
all responding to the noise CS during the extinction tests, maxi‐
mum F(1,32) = 2.814, p = 0.103. The analysis by extinction trials 
within the one‐day session showed the expected effect of blocks, 
F(5,150) = 13.405, p < 0.001, because responding reduced as 
the session progressed (block 1 M = 3.937 ± 0.494; block 5 
M = 1.285 ± 0.263). However, there were no significant interactions 
involving prior drug group and block, both Fs <1. Neither were there 
any effects involving drug in the ITI, maximum F(1,32) = 1.736, 
p = 0.197. There were, however, main effects of both condition‐
ing trace, F(1,32) = 20.663, p < 0.001, and prior drug on respond‐
ing in the 5 s after noise presentations (post‐CS), F(1,32) = 7.180, 
p = 0.012, as well as a drug × trace interaction, F(1,32) = 6.139, 
p = 0.019. The pattern of effects was similar to that seen on CS 
responding during acquisition: Responding post‐CS was reduced 
in rats previously conditioned under scopolamine. As shown in 
Table 2A, this difference between scopolamine‐ and saline‐infused 
groups was clear in the 2 s trace conditioned group, p = 0.001. The 
post‐CS difference between the saline versus scopolamine 10 s 
trace conditioned groups was not significant, p = 0.890.
Light background
As per the noise CS, there was no overall effect of prior trace or 
drug group on total responding to the light stimulus during the ex‐
tinction tests, maximum F(1,32) = 2.568, p = 0.119. The analysis by 
trials showed some effect of blocks, F(5,165) = 2.124, p = 0.065, sig‐
nificant in the linear trend, F(1,33) = 5.286, p = 0.028. As might be 
expected, responding to the light stimulus was less than that seen 
to the noise CS; nonetheless, from a lower baseline, responding re‐
duced as the session progressed (block 1 M = 0.758 ± 0.229; block 
5 M = 0.161 ± 0.090). As was the case for the CS responding, there 
were no significant interactions involving prior drug group and block, 
both Fs <1. However, ANOVA of responding during the light tests 
did show a main effect of prior drug post‐stimulus, F(1,33) = 4.915, 
p = 0.034, in the absence of any other significant effects or inter‐
actions, maximum F(1,33) = 2.235, p = 0.144. Responding post‐
stimulus was overall reduced in rats previously conditioned under 
scopolamine (Table 2B).
3.1.7 | Effects of scopolamine in dorsal 
hippocampus on locomotor activity
Groups were not evenly matched in that there was an effect of drug 
condition‐to‐be during the test day habituation, F(1,22) = 4.926, 
p = 0.037. This effect arose because rats allocated to the saline infu‐
sion condition were initially more active (M = 324.667 ± 17.859) than 
those allocated to the scopolamine condition (M = 268.611 ± 17.859). 
However, post‐infusion, the effect of drug F(1,22) = 44.802, 
p < 0.001, took the form that scopolamine‐treated rats were more 
active (M = 447.903 ± 32.373) than those infused with saline 
(M = 141.458 ± 32.373). As shown in Figure 4, this effect was con‐
sistent across the test session in that whilst there was a main effect 
of blocks, F(5,110) = 35.973, p < 0.001, the drug‐by‐block interac‐
tion was not significant, F(5,110) = 2.237, p = 0.056.
4  | DISCUSSION
Intra‐hippocampal infusion of scopolamine (within the range of 
infusion sites shown in Figure 1) reduced responding to a trace 
F I G U R E  3   Mean total nose‐pokes are shown as a function 
of the 4 days of conditioning (a) during the 2 s inter‐stimulus 
interval and (b) during the 10 s inter‐stimulus interval. Gray circles 
denote rats conditioned after bilateral microinfusion into dorsal 
hippocampus of scopolamine at (30 µg in 0.5 µl/side) or saline 
vehicle. White circles denote rats conditioned after microinfusion 
of saline vehicle. N = 9–10 rats per group. Error bars represent the 
standard error of the mean
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conditioned CS, an effect most clearly seen when the food US (two 
sucrose pellets) was presented at a 2 but not at a 10 s trace inter‐
val (possibly because of a floor effect in conditioning to the CS pre‐
sented at 10 s; Figure 2b). The same pattern of results was confirmed 
drug‐free in the extinction tests of conditioned responding render‐
ing direct nonspecific effects of the scopolamine treatment an un‐
likely account of trace conditioning impairment (post‐CS, Table 2A). 
Moreover, in contrast to its effects in the ISI (Figure 3), respond‐
ing in the ITI was unaffected by scopolamine infusion. In a separate 
measure in a different apparatus, LMA was increased under scopola‐
mine (Figure 4). Taken together, these data suggest that nonspecific 
changes in motor activity provide no account of reduced trace con‐
ditioning as measured by reduced CS responding.
There was also some overall reduction in responding immediately 
after the sucrose pellet US was delivered. However, as Figure 2c 
shows, responding was nonetheless sufficiently high to ensure col‐
lection of the 30 US deliveries over the course of the conditioning 
session (and none was left at the end of the session). Additionally, 
the effect of scopolamine on US responding was different to that 
seen in the case of the CS in that the reduction in US responding 
was significant at the 10 s but not at the 2 s trace interval. Thus, 
motivational differences, specifically loss of interest in the sucrose 
US after scopolamine infusion, do not provide a compelling account 
of the differences in CS responding.
The drug‐free extinction sessions provide further evidence as 
to whether scopolamine interfered with the acquisition and/or con‐
solidation of the CS‐US association as distinct from the ability to 
perform the nose‐poke response during acquisition. In the previous 
fear conditioning study (Pang et al., 2010), intra‐hippocampal sco‐
polamine reduced freezing CRs, even in a hippocampus‐independent 
delay conditioning group. The authors discussed the possibility that 
this was due to increased locomotion, shown also in the present 
study, which could interfere with freezing or (in the present study) 
nose‐poking for food. The CS data from the extinction session did 
not show any effect of prior trace or drug group (Table 2A). The 
overall reduced responding during the extinction tests can be at‐
tributed to the change in context (due to the absence of the after‐ef‐
fects of the infusions and the fact that food was no longer available). 
Nonetheless, analysis of post‐CS responding suggested impaired 
expression of appetitive trace conditioning in rats previously condi‐
tioned under scopolamine at the 2 s ISI.
The introduction of a trace interval allows for more than the pas‐
sage of time and the need for a memory trace in that contextual 
cues intervene between CS offset and US delivery and may help to 
TA B L E  2   Mean total nose‐poke responding (±SEM) during different parts of the extinction sessions for (A) the noise conditioned stimulus 
(CS) and (B) the light background stimulus, by the previously conditioned trace and drug infusion groups. The CS or light background 
presentations were each of 5 s duration. Responding post‐CS or post‐stimulus was similarly recorded over a 5 s duration. Responding in the 
remainder of the session was in the inter‐trial interval (ITI). N = 8–10/cell
Trace 2 s 10 s
Drug infusion Saline





Tone CS 14.300 (±2.175) 12.778 (±2.293) 7.250 (±2.432) 12.111 (±2.293)
Post‐CS 16.200 (±1.626) 7.333*** (±1.714) 4.125 (±1.818) 3.778 (±1.714)
ITI 83.100 (±15.457) 120.222 (±16.293) 98.375 (±17.281) 105.556 (±16.293)
(B)
Light background 3.400 (±0.991) 1.667 (±1.045) 3.625 (±1.108) 2.000 (±1.045)
Post‐stimulus 3.300 (±0.799) 2.667# (±0.842) 4.375 (±0.893) 1.444# (±0.842)
ITI 82.300 (±20.704) 96.778 (±21.824) 93.375 (±23.148) 66.111 (±21.824)
Note. Asterisks indicate a significant difference by prior infusion group as compared to the corresponding 2 s‐conditioned saline group with ***p = 0.0001. 
Hash signs indicate the overall effect of having been conditioned under scopolamine with #p < 0.05.
F I G U R E  4   Effect of microinfusion of scopolamine on 
spontaneous activity. Rats were habituated to the activity 
chambers for 30 min before bilateral microinfusion of scopolamine 
at 30 µg in 0.5 µl/side (gray circles) or saline vehicle (white circles). 
Locomotor activity was then monitored for an additional 60 min. 
N = 12 rats per group. Error bars represent the standard error of 
the mean
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bridge the gap in normal animals (Quinn et al., 2002). Moreover, as 
per our earlier studies, we used an experimental background stimu‐
lus to provide an additional measure of effects on contextual condi‐
tioning as assessed in drug‐free extinction tests (Pezze et al., 2015, 
2017). In the present study, intra‐hippocampal scopolamine also 
reduced responding after test presentations of the light experimen‐
tal background (Table 2B). This action is consistent with impaired 
contextual conditioning to this aspect of the context. However, we 
found a different profile of effects in the ISI and the ITI during acqui‐
sition. There was no reduction in ITI responding after intra‐hippo‐
campal scopolamine. In the ISI, saline‐infused rats showed increased 
responding over the course of conditioning, and the acquisition of 
anticipatory responding within the trace intervals was depressed 
under scopolamine (Figure 3). Different profiles of responding in the 
ITI and ISI suggest that rats treated with scopolamine discriminated 
the ISI from the ITI. The effect of intra‐hippocampal scopolamine 
in the ISI resembled the effect on associative learning: depressed 
anticipatory responding during CS presentations.
Thus, the results suggest that nonspecific changes in activity or 
motivation to respond for the US cannot explain the reduction in 
trace conditioning as measured by reduced CS responding and in the 
ISI. Rather, the findings of the present study point to the importance 
of associative aspects of the task in determining its sensitivity to the 
effects of scopolamine, because these were different by trace and 
depended on the period of the conditioning session under analysis 
(i.e., whether CS, US, ISI, or ITI). These findings further suggest that 
muscarinic receptors in the hippocampus are important modulators 
of short‐term working memory of the kind required to hold informa‐
tion “online” (Levy & Goldman‐Rakic, 2000; Sweatt, 2004). Before 
considering the wider implications of the findings, we first discuss 
the limitations of the present study.
4.1 | Were the conditioning parameters appropriate 
to test the role of hippocampus?
It has long been suggested that temporal discontiguity is the critical 
factor, which renders trace conditioning reliant on the hippocam‐
pus (Rawlins, 1985; Wallenstein, Eichenbaum, & Hasselmo, 1998) 
and there is evidence in support of this contention (Bangasser et al., 
2006). In the present study, the use of the 10 s trace was intended 
to increase the level of temporal discontiguity, a manipulation which 
might be expected to make trace conditioning more dependent on 
hippocampal function. However, in the present study the effect of 
scopolamine infusion in the dorsal hippocampus was demonstrated 
at the short 2 s rather than at the long 10 s trace interval.
Chan et al. (2014) showed the importance of the trace interval 
in relation to the ITI for the demonstration of trace conditioning in 
normal animals. Therefore, these temporal factors can also be im‐
portant determinants of whether effects of hippocampal lesions 
may be demonstrated. Thibaudeau et al. (2007) earlier examined 
the performance of normal rats when the trace was systematically 
extended up to 8 s, finding that normal rats did not learn at an 8 s 
trace interval even after 200 trials. However, Chan et al showed 
than intact rats can learn trace conditioning with ISIs of 8 s and 
even 60 s, with successful conditioning at 8 s requiring an ITI of 
300 s.
Thus, the work of Thibaudeau et al. (2007) and Chan et al. (2014) 
suggests that our ITI was likely too short to support conditioning at 
the longer 10 s trace interval. However, we had the constraint that 
we were working with an earlier established method adapted for 
microinfusion studies to deliver 30 trials within just over 1 hr (over 
which time the majority of drug treatments can be assumed to main‐
tain their effectiveness). Moreover, we have previously found that 
(at least in the 2 s trace conditioned group) learning is reliably shown 
within 4 days. It was advisable to keep our conditioning parame‐
ters consistent to allow direct comparison between experiments, in 
particular an earlier study showing that appetitive but not aversive 
trace conditioning was impaired by systemic scopolamine (Pezze et 
al., 2017).
A further limitation arising from the adoption of the previously 
used design and procedural parameters is that we did not include 
delay conditioning or explicitly unpaired groups. We previously 
employed delay conditioning controls in the aversive but not in the 
appetitive procedure used to examine the effects of systemic sco‐
polamine (Pezze et al., 2017). However, the appetitive procedure has 
a number of inbuilt controls for nonspecific effects. For example, 
differences in unconditioned effects would be expected to be equiv‐
alent across behavioral conditions. We are interested in differences 
by trace interval. Moreover, other appetitive trace studies of the 
hippocampus (e.g., Chan et al., 2014; Thibaudeau et al., 2007, 2009) 
have specifically compared short and long trace intervals similar to 
those used in this experiment.
4.2 | Were the conditioning parameters appropriate 
to examine (effects on) timing?
In principle, we might have identified effects on timing since we 
measured the distribution of the responding within the 10 s trace 
in the present study. Tam and Bonardi (2012) found that whilst 
excitotoxic lesions to dorsal hippocampus were without effect on 
the acquisition of appetitive trace conditioning, they selectively 
affected the distribution of conditioned responding to the trace 
CS in the early stages of acquisition and impaired the timing of CRs 
as measured in the distribution of CRs during the trace CS pres‐
entations. Specifically, hippocampal lesioned rats underestimated 
the time of US delivery and responded earlier than the sham‐le‐
sioned controls. Tam and Bonardi (2012) suggest that a failure to 
examine changes in the timing of CR production may account for 
the lack of hippocampal lesion effects in earlier appetitive studies, 
since the majority of these studies have failed to examine when 
the CR will occur as is more typical in eyeblink conditioning stud‐
ies. The focus on averaged responding may show a negative result 
because the overall level of responding to the trace CS is unaf‐
fected. Moreover, the effect of hippocampal lesions on CR tim‐
ing was transient, restricted to the first half of acquisition (Tam & 
Bonardi, 2012).
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In the present study, we did not find any evidence to suggest 
impaired timing within the trace interval: Statistically, there was no 
interaction between drug infusion and the 2 s bins of the 10 s trace 
interval. However, it should be acknowledged that the conditioning 
schedule used in the present study may have been insufficient for 
the vehicle controls to show the development of timing in the 10 s 
trace ISI. We earlier examined the effects of systemic drug treat‐
ments on (the development of) the distribution of responding within 
the ISI of this kind of procedure. After 5 days’ acquisition at 10 tri‐
als/day, there were no significant effects of bins (Cassaday, Finger, 
& Horsley, 2008). However, effects of bins (moderated by systemic 
drug treatments) were seen when conditioning was conducted over 
10 days’ acquisition at 10 trials/day (Cassaday et al., 2008; Kantini, 
Norman, & Cassaday, 2004). Subsequent microinfusion studies 
have used a more intensive conditioning schedule identical to that 
adopted in the present study (conducted over 4 days, each of 30 
trials, in order to limit the number of microinfusion sessions; Pezze 
et al., 2015, 2017). Responding increased within the 10 s ISI over 
the course of acquisition and scopolamine depressed ISI respond‐
ing (both systemic and following microinfusion in prefrontal cortex; 
Pezze et al., 2017). However, there were no significant interactions 
between treatment and bins for responding within the 10 s trace in 
our earlier microinfusion studies either (Pezze et al., 2015, 2017). In 
the present study, the increase in responding within the 2 s trace 
was less marked in rats treated with scopolamine. Similarly, scopol‐
amine‐treated rats responded overall less in the 10 s ISI but without 
any evidence consistent with an effect on timing. In the 10 s trace, 
the effect of bins arose because there was some relatively increased 
responding toward the middle to later portion of the trace interval, 
but responding was not increased in the final bin suggesting that 
timing was not fully developed. Moreover, (the acquisition of) the 
distribution of responding within the 10 s trace was unaffected by 
drug (which was significant only as a main effect). Thus, it seems 
that the use of a procedure optimized for microinfusions in effect 
precluded examination of (effects on) timing.
4.3 | The role of additional conditioning mechanisms
In addition to the possibility that effects on timing could have been 
identified if the trials had been distributed over a greater number 
of days, there are other underlying cognitive mechanisms which 
the present study cannot distinguish. We have focused on CS re‐
sponding as the measure of associative learning in the present task. 
However, if as we would wish to argue, the ISI is discriminated from 
the ITI, the procedure in use may amount to sequential condition‐
ing (Baeyens, Vansteenwegen, Hermans, Vervliet, & Eelen, 2001). As 
shown in Figure 3a, responding in the 2 s ISI progressively increased 
over the 4 days of conditioning consistent with the development of 
anticipatory responding in the trace interval as well as to the CS.
Moreover, there is good evidence to suggest that the learning of 
sequential discriminations results in occasion setting. In other words, 
rather than the CS eliciting the nose‐poking CR because it signals the 
occurrence of the US, it may rather set the occasion for responding in 
the subsequent trace interval (Holland, 1989, 1992). Contexts (such as 
that provided by the ITI in the present study) are more typically viewed 
as occasion setters for CS‐US relations (Bouton & Swartzentruber, 
1986). Furthermore, just as the same experimental stimulus can have 
the role of both CS and occasion setter (Holland, 1992), the same has 
been suggested to apply for contextual cues (Bouton, 2010). In the 
present study, the differences in responding show that the mini‐con‐
text of the ISI trace is functionally different from the ITI; the context 
predicts the US only on the specific occasions when it has been sig‐
naled by the preceding CS. Thus, effects of intra‐hippocampal scopol‐
amine mediated by occasion setting are not excluded.
4.4 | Selectivity of the microinfusion procedure
With respect to the selectivity of the microinfusion procedure, the 
expected spread of a 0.5 µl injection is around 1 mm (Allen et al., 
2008; Bast & Feldon, 2003; Myers, 1966). The minimally pharmaco‐
logically active concentration of scopolamine beyond the immedi‐
ate spread of the bolus and wider diffusion radius is unknown, and 
the drug infusion may also have spread up the cannula tract (Wise 
& Hoffman, 1992). However, dorsal hippocampus spans a relatively 
large area, extending around 3 mm in the mediolateral plane for ex‐
ample (Paxinos & Watson, 1998). Moreover, the area is covered with 
fibers, which limit diffusion to extra‐hippocampal structures (Morris, 
Halliwell, & Bowery, 1989). Diffusion to ventral hippocampus can 
similarly be excluded based on likely spread of the 0.5 µl injection 
volume and its relative positioning.
It is therefore reasonable to assume that we have examined the 
effects of scopolamine in (part of) dorsal hippocampus. This distinc‐
tion matters given the compelling body of evidence for functional 
differentiation along the septotemporal axis of the hippocampus 
(Bannerman et al., 2004; Bast & Feldon, 2003; Strange, Witter, Lein, 
& Moser, 2014). Moreover, electrophysiological evidence has con‐
firmed relatively greater neuronal activation in dorsal than in ventral 
hippocampus during CS presentations and the trace interval of an 
eyeblink conditioning procedure (Weible et al., 2006). On this basis, 
the effects of scopolamine observed in the present study would not 
be expected to reproduce following infusion restricted to ventral 
hippocampus. Though since excitotoxic lesions extending also to 
include ventral hippocampus similarly impair aversive trace condi‐
tioning (Bangasser et al., 2006), there are no grounds to suppose that 
any spread to ventral hippocampus should counteract the effects of 
infusion in dorsal hippocampus.
Although not directly examined in the present study, a role for 
ACh nicotinic receptors should also be considered. In appetitive 
conditioning procedures similar to those used in the present study, 
systemic nicotine was without effect on 10 s trace conditioning but a 
2 s interval was not examined (Cassaday et al., 2008). In conditioned 
freezing procedures, systemic nicotine‐enhanced trace conditioning 
in mice (Gould, Feiro, & Moore, 2004) and the key brain substrates 
mediating nicotinic ACh receptor modulation of trace conditioning 
have been found to include hippocampus as well as mPFC (Raybuck 
& Gould, 2010).
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4.5 | Generality of the findings
With respect to the generality of the findings, we did not directly 
compare the effects of scopolamine in aversive conditioning in the 
present study. However, using the identical appetitive behavioral 
procedure, Pezze et al. (2017) compared the effects of systemic sco‐
polamine in aversive trace conditioning procedure. Since systemic 
scopolamine was without effect in the aversive procedure, we went 
on to examine the effects of microinfusions (in this case in mPFC) 
using the appetitive procedure only. The same rationale was applied 
in the present study without further use of animals in the aversive 
variant. However, scopolamine microinfused in hippocampus might 
nonetheless have had an effect on aversive trace conditioning. 
Indeed, Pang et al. (2010) reported just such an effect with scopola‐
mine infusions in dorsal hippocampus (30 µg/side).
As a first step, and in common with the other studies conducted 
within the same project, the present study used male Wistar rats. 
There have been few reports of sex differences in appetitively mo‐
tivated procedures (Prendergast, Onishi, & Zucker, 2014). Future 
studies should also include females to rectify this omission, partic‐
ularly if further comparisons with aversively motivated procedures 
are to be drawn. Although in aversively motivated behaviors there 
is evidence that stage of the estrous cycle results in behavioral vari‐
ability in rodents, meta‐analysis of 293 studies suggests that estrous 
cycle makes little or no difference to the performance of explor‐
atory or appetitive tasks; indeed, behavioral variability may even be 
greater in males (Prendergast et al., 2014).
4.6 | Implications
The role of ACh in trace conditioning is consistent with other evi‐
dence for its role in attention (Sarter, Parikh, & Howe, 2009), learn‐
ing (Hangya, Ranade, Lorenc, & Kepecs, 2015), working memory 
(Teles‐Grilo Ruivo et al., 2017), and reward (Hangya et al., 2015). 
Trace conditioning already shows good translational validity as 
model of hippocampal‐dependent memory function (Bangasser et 
al., 2006; Sweatt, 2004). The present study extends on these find‐
ings to suggest the further potential of cholinergic treatments, to 
target muscarinic receptors as a treatment strategy for working 
memory enhancement, selectively in dorsal hippocampus when 
regional activation is feasible (although nicotinic receptors may 
also play some role; Gould et al., 2004; Raybuck & Gould, 2010). 
Neuromodulatory effects of ACh in cortical regions may also be 
important (Hasselmo, 1999; Sarter et al., 2009; Teles‐Grilo Ruivo 
et al., 2017). Indeed, using the same appetitive trace conditioning 
procedures, we have found a similar profile of neuromodulation 
after microinfusion in mPFC (Pezze et al., 2017). Flesher, Butt, and 
Kinney‐Hurd (2011) systematically compared ACh release measured 
by microdialysis probes in hippocampus and mPFC during appetitive 
trace and delay conditioning. The results showed that ACh release in 
both structures was correlated with trace but not delay condition‐
ing performance (Flesher et al., 2011). The similarity between the 
effects of scopolamine in hippocampus and mPFC is also consistent 
with evidence for the coordination of tonic ACh release in dorsal 
hippocampus and mPFC during performance of a rewarded work‐
ing memory task (Teles‐Grilo Ruivo et al., 2017). In future research, 
such functional interactions should be further investigated using dis‐
connection procedures, to compare the effects of bilateral infusion 
of scopolamine in hippocampus and mPFC (Pezze et al., 2017) with 
those of unilateral infusion of scopolamine in hippocampus com‐
bined with the contralateral infusion in mPFC.
ACKNOWLEDG MENTS
We thank Rachel Victory, for assistance with behavioral testing.
CONFLIC T OF INTERE S T
The authors have no competing financial interests and nothing to 
disclose.
ORCID
Helen J. Cassaday  http://orcid.org/0000‐0002‐9227‐373X 
R E FE R E N C E S
Allen, T. A., Narayanan, N. S., Kholodar‐Smith, D. B., Zhao, Y., Laubach, 
M., & Brown, T. H. (2008). Imaging the spread of reversible brain 
inactivations using fluorescent muscimol. Journal of Neuroscience 
Methods, 171, 30–38. https://doi.org/10.1016/j.jneumeth.2008.01. 
033
Baeyens, F., Vansteenwegen, D., Hermans, D., Vervliet, B., & Eelen, P. 
(2001). Sequential and simultaneous feature positive discrimina‐
tions: Occasion setting and configural learning in human Pavlovian 
conditioning. Journal of Experimental Psychology: Animal Behavior 
Processes, 27, 279–295. https://doi.org/10.1037/0097‐7403.27. 
3.279
Bang, S. J., & Brown, T. H. (2009). Muscarinic receptors in perirhinal 
cortex control trace conditioning. Journal of Neuroscience, 29, 4346–
4350. https://doi.org/10.1523/JNEUROSCI.0069‐09.2009
Bangasser, D. A., Waxler, D. E., Santollo, J., & Shors, T. J. (2006). Trace 
conditioning and the hippocampus: The importance of contiguity. 
Journal of Neuroscience, 26, 8702–8706. https://doi.org/10.1523/
JNEUROSCI.1742‐06.2006
Bannerman, D. M., Rawlins, J. N. P., McHugh, S. B., Deacon, R. M. 
J., Yee, B. K., Bast, T., … Feldon, J. (2004). Regional dissociations 
within the hippocampus‐memory and anxiety. Neuroscience and 
Biobehavioral Reviews, 28, 273–283. https://doi.org/10.1016/j.
neubiorev.2004.03.004
Bast, T., & Feldon, J. (2003). Hippocampal modulation of sensorimo‐
tor processes. Progress in Neurobiology, 70, 319–345. https://doi.
org/10.1016/S0301‐0082(03)00112‐6
Baysinger, A. N., Kent, B. A., & Brown, T. H. (2012). Muscarinic receptors 
in amygdala control trace conditioning. PLoS One, 7, e45720.
Bouton, M. E. (2010). The multiple forms of “context” in associative 
learning theory. In B. Mesquita, L. F. Barret, & E. R. Smith (Eds.), The 
mind in context (pp. 233–258). New York, NY: Guilford Press.
Bouton, M. E., & Swartzentruber, D. (1986). Analysis of the asso‐
ciative and occasion‐setting properties of contexts partici‐
pating in a Pavlovian discrimination. Journal of Experimental 
Psychology: Animal Behavior Processes, 12, 333–350. https://doi.
org/10.1037/0097‐7403.12.4.333
12 of 13  |     PEZZE Et al.
Cassaday, H. J., Finger, B. C., & Horsley, R. R. (2008). 
Methylphenidate and nicotine focus responding to an informa‐
tive discrete CS over successive sessions of appetitive condi‐
tioning. Journal of Psychopharmacology, 22, 849–859. https://doi.
org/10.1177/0269881107083842
Chan, K., Shipman, M. L., & Kister, E. (2014). Selective hippocampal le‐
sions impair acquisition of appetitive trace conditioning with long 
intertrial and long trace intervals. Behavioral Neuroscience, 128, 92–
102. https://doi.org/10.1037/a0035606
Chen, H., Yang, L., Xu, Y., Wu, G.‐Y., Yao, J., Zhang, J., … Hu, B. 
(2014). Prefrontal control of cerebellum‐dependent associative 
motor learning. Cerebellum, 13, 64–78. https://doi.org/10.1007/
s12311‐013‐0517‐4
Flesher, M. M., Butt, A. E., & Kinney‐Hurd, B. L. (2011). Differential ace‐
tylcholine release in the prefrontal cortex and hippocampus during 
Pavlovian trace and delay conditioning. Neurobiology of Learning and 
Memory, 96, 181–191. https://doi.org/10.1016/j.nlm.2011.04.008
Gould, T. J., Feiro, O., & Moore, D. (2004). Nicotine enhances trace 
cued fear conditioning but not delay cued fear conditioning in 
C57BL/6 mice. Behavioral Brain Research, 155, 167–173. https://doi.
org/10.1016/j.bbr.2004.04.009
Hangya, B., Ranade, S. P., Lorenc, M., & Kepecs, A. (2015). Central cholin‐
ergic neurons are rapidly recruited by reinforcement feedback. Cell, 
162, 1155–1168. https://doi.org/10.1016/j.cell.2015.07.057
Hasselmo, M. E. (1999). Neuromodulation: Acetylcholine and memory 
consolidation. Trends in Cognitive Sciences, 3, 351–359. https://doi.
org/10.1016/S1364‐6613(99)01365‐0
Holland, P. C. (1989). Acquisition and transfer of conditional discrimina‐
tion performance. Journal of Experimental Psychology: Animal Behavior 
Processes, 15, 154–165. https://doi.org/10.1037/0097‐7403.15.2.154
Holland, P. C. (1992). Occasion setting in pavlovian conditioning. In D. L. 
Medin (Ed.), The psychology of learning and motivation: advances in re-
search and theory (Vol. 28, pp. 69–125). San Diego, CA: Academic Press.
Hunt, P. S., & Richardson, R. (2007). Pharmacological dissociation of 
trace and long‐delay fear conditioning in young rats. Neurobiology 
of Learning and Memory, 87, 86–92. https://doi.org/10.1016/j.
nlm.2006.06.003
Jones, C. A., Brown, A. M., Auer, D. P., & Fone, K. C. (2011). The mGluR2/3 
agonist LY379268 reverses post‐weaning social isolation‐induced 
recognition memory deficits in the rat. Psychopharmacology (Berlin), 
214, 269–283. https://doi.org/10.1007/s00213‐010‐1931‐7
Kaneko, T., & Thompson, R. F. (1997). Disruption of trace conditioning 
of the nictitating membrane response in rabbits by central choliner‐
gic blockade. Psychopharmacology (Berlin), 131, 161–166. https://doi.
org/10.1007/s002130050279
Kantini, E., Norman, C., & Cassaday, H. J. (2004). Amphetamine de‐
creases the expression and acquisition of appetitive conditioning 
but increases the acquisition of anticipatory responding over a trace 
interval. Journal of Psychopharmacology, 18, 516–526. https://doi.
org/10.1177/0269881104047279
Levy, R., & Goldman‐Rakic, P. S. (2000). Segregation of working memory 
functions within the dorsolateral prefrontal cortex. Experimental Brain 
Research, 133, 23–32. https://doi.org/10.1007/s002210000397
Morris, R. G., Halliwell, R. F., & Bowery, N. (1989). Synaptic plasticity 
and learning II: Do different kinds of plasticity underlie differ‐
ent kinds of learning? Neuropsychologia, 27, 41–59. https://doi.
org/10.1016/0028‐3932(89)90089‐4
Myers, R. D. (1966). Injection of solutions into cerebral tissue: Relation 
between volume and diffusion. Physiology & Behavior, 1, 171–174. 
https://doi.org/10.1016/0031‐9384(66)90064‐3
Pang, M. H., Kim, N. S., Kim, I. H., Kim, H., Kim, H. T., & Choi, J. S. (2010). 
Cholinergic transmission in the dorsal hippocampus modulates trace 
but not delay fear conditioning. Neurobiology of Learning and Memory, 
94, 206–213. https://doi.org/10.1016/j.nlm.2010.05.008
Paxinos, G., & Watson, C. (1998). The rat brain in stereotaxic coordinates 
(4th ed.). New York, NY: Academic Press.
Pezze, M. A., Marshall, H. J., & Cassaday, H. J. (2015). Dopaminergic 
modulation of appetitive trace conditioning: The role of D1 recep‐
tors in medial prefrontal cortex. Psychopharmacology (Berlin), 232, 
2669–2680.
Pezze, M. A., Marshall, H. J., & Cassaday, H. J. (2017). Scopolamine 
impairs appetitive but not aversive trace conditioning: Role of the 
medial prefrontal cortex. Journal of Neuroscience, 37, 6289–6298. 
https://doi.org/10.1523/JNEUROSCI.3308‐16.2017
Pezze, M. A., Marshall, H. J., Fone, K. C. F., & Cassaday, H. J. (2015). 
Dopamine D1 receptor stimulation modulates the formation and 
retrieval of novel object recognition memory: Role of the prelimbic 
cortex. European Neuropsychopharmacology, 25, 2145–2156.
Prendergast, B. J., Onishi, K. G., & Zucker, I. (2014). Female mice liberated 
for inclusion in neuroscience and biomedical research. Neuroscience 
and Biobehavioral Reviews, 40, 1–5. https://doi.org/10.1016/j.
neubiorev.2014.01.001
Quinn, J. J., Oommen, S. S., Morrison, G. E., & Fanselow, M. S. (2002). 
Post‐training excitotoxic lesions of the dorsal hippocampus attenu‐
ate forward trace, backward trace, and delay fear conditioning in a 
temporally specific manner. Hippocampus, 12, 495–504. https://doi.
org/10.1002/hipo.10029
Rawlins, J. N. P. (1985). Associations across time: The hippocampus as a 
temporary memory store. The Behavioral and Brain Sciences, 8, 479–
497. https://doi.org/10.1017/S0140525X00001291
Raybuck, J. D., & Gould, T. J. (2010). The role of nicotinic acetylcholine 
receptors in the medial prefrontal cortex and hippocampus in trace 
fear conditioning. Neurobiology of Learning and Memory, 94, 353–363. 
https://doi.org/10.1016/j.nlm.2010.08.001
Sarter, M., Parikh, V., & Howe, W. M. (2009). Phasic acetylcholine re‐
lease and the volume transmission hypothesis: Time to move on. 
Nature Reviews Neuroscience, 10, 383–390. https://doi.org/10.1038/
nrn2635
Seager, M. A., Asaka, Y., & Berry, S. D. (1999). Scopolamine disruption of 
behavioral and hippocampal responses in appetitive trace classical 
conditioning. Behavioural Brain Research, 100, 143–151. https://doi.
org/10.1016/S0166‐4328(98)00123‐5
Strange, B. A., Witter, M. P., Lein, E. S., & Moser, E. I. (2014). Functional 
organization of the hippocampal longitudinal axis. Nature Reviews 
Neuroscience, 15, 655–669. https://doi.org/10.1038/nrn3785
Sweatt, J. D. (2004). Hippocampal function in cognition. 
Psychopharmacology (Berlin), 174, 99–110. https://doi.org/10.1007/
s00213‐004‐1795‐9
Tam, S. K. E., & Bonardi, C. (2012). Dorsal hippocampal involvement 
in appetitive trace conditioning and interval timing. Behavioral 
Neuroscience, 126, 258–269. https://doi.org/10.1037/a0027164
Teles‐Grilo Ruivo, L. M., Baker, K. L., Conway, M. W., Kinsley, P. J., 
Gilmour, G., Phillips, K. G., … Mellor, J. R. (2017). Coordinated acetyl‐
choline release in prefrontal cortex and hippocampus is associated 
with arousal and reward on distinct timescales. Cell Reports, 18, 905–
917. https://doi.org/10.1016/j.celrep.2016.12.085
Thibaudeau, G., Doré, F. Y., & Goulet, S. (2009). Additional evidence for 
intact appetitive trace conditioning in hippocampal‐lesioned rats. 
Behavioral Neuroscience, 123, 707–712. https://doi.org/10.1037/
a0015239
Thibaudeau, G., Potvin, O., Allen, K., Doré, F. Y., & Goulet, S. (2007). 
Dorsal, ventral, and complete excitotoxic lesions of the hippocampus 
in rats failed to impair appetitive trace conditioning. Behavioral Brain 
Research, 185, 9–20. https://doi.org/10.1016/j.bbr.2007.07.004
Thomas, J. D., & Tran, T. D. (2012). Choline supplementation mitigates 
trace, but not delay, eyeblink conditioning deficits in rats exposed to 
alcohol during development. Hippocampus, 22, 619–630. https://doi.
org/10.1002/hipo.20925
     |  13 of 13PEZZE Et al.
Wallenstein, G. V., Eichenbaum, H., & Hasselmo, M. E. (1998). 
The hippocampus as an associator of discontiguous events. 
Trends in Neurosciences, 21, 317–323. https://doi.org/10.1016/
S0166‐2236(97)01220‐4
Weible, A. P., McEchron, M. D., & Disterhoft, J. F. (2000). Cortical in‐
volvement in acquisition and extinction of trace eyeblink con‐
ditioning. Behavioral Neuroscience, 114, 1058–1067. https://doi.
org/10.1037/0735‐7044.114.6.1058
Weible, A. P., O’Reilly, J. A., Weiss, C., & Disterhoft, J. F. (2006). 
Comparisons of dorsal and ventral hippocampus cornu ammonis 
region 1 pyramidal neuron activity during trace eye‐blink condi‐
tioning in the rabbit. Neuroscience, 141, 1123–1137. https://doi.
org/10.1016/j.neuroscience.2006.04.065
Weible, A. P., Weiss, C., & Disterhoft, J. F. (2003). Activity profiles of sin‐
gle neurons in caudal anterior cingulate cortex during trace eyeblink 
conditioning in the rabbit. Journal of Neurophysiology, 90, 599–612. 
https://doi.org/10.1152/jn.01097.2002
Wise, R. A., & Hoffman, D. C. (1992). Localization of drug reward mech‐
anisms by intracranial injections. Synapse (New York, N. Y.), 10, 247–
263. https://doi.org/10.1002/syn.890100307
How to cite this article: Pezze MA, Marshall HJ, Cassaday HJ. 
Infusions of scopolamine in dorsal hippocampus reduce 
anticipatory responding in an appetitive trace conditioning 
procedure. Brain Behav. 2018;e01147. https://doi.
org/10.1002/brb3.1147
